Insights into the interaction of CD4 with anti-CD4 antibodies

被引:3
|
作者
Van-Chien Bui [1 ,2 ]
Thi-Huong Nguyen [2 ]
机构
[1] Univ Med Greifswald, Ctr Innovat Competence Humoral Immune React Cardi, D-17489 Greifswald, Germany
[2] Univ Med Greifswald, Inst Immunol & Transfus Med, D-17475 Greifswald, Germany
关键词
CD4-antibody interaction; Binding strength; Thermodynamics; Kinetics; Assembly states; PROTEIN KINASE P56LCK; SIGNAL-TRANSDUCTION; FORCE SPECTROSCOPY; CELL-ADHESION; HEAT-CAPACITY; VIRUS-BINDING; HIV-1; GP120; RECEPTOR; ANTIGEN; EPITOPE;
D O I
10.1016/j.imbio.2016.10.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Knowledge about the mechanism by which some antibodies can block HIV-1 entry is critical to our understanding of their function and may offer new avenues for controlling the adhesion of HIV-1 to the host cells. While much progress has been made, this mechanism remains unclear. Here, atomic force microscopy, isothermal titration calorimetry (ITC), and circular dichroism spectroscopy were used to measure some biophysical characteristics of the interaction of fouf-domains (D1-D4) membrane protein CD4 with anti-D3 antibody OKT4 and with HIV-1 entry blocking anti-D1 antibody Leu3a. The results showed that at 37 degrees C they bind with similar binding strength, thermodynamics, and kinetics but with different assembly states. Further analyzing the interactions at different temperatures by ITC showed that binding of CD4 with Leu3a is characteristic for specific hydrophobic binding as well as for protein folding while with OKT4 comes from an extensive additional hydration upon binding and charge-related interactions within the binding site. Comparing these characteristics with those of HIV-1 gp120-CD4 interaction revealed that Leu3a binds to CD4 faster than HIV-1 followed by changing local structure of D1 to which HIV-1 binds leading to a prevention of viral entry. (C) 2016 Elsevier GmbH. All rights reserved.
引用
收藏
页码:148 / 154
页数:7
相关论文
共 50 条
  • [1] CD4~+ T Cell Apoptosis Induced by Anti-CD4 Antibodies
    张智红
    张悦
    朱惠芬
    杨敬
    沈关心
    Journal of Tongji Medical University, 2000, (02) : 100 - 102
  • [2] EFFECT OF ANTI-CD4 ON CD4 SUBSETS .1. ANTI-CD4 PREFERENTIALLY DELETES RESTING, NAIVE CD4 CELLS AND SPARES ACTIVATED CD4 CELLS
    CHACE, JH
    COWDERY, JS
    FIELD, EH
    JOURNAL OF IMMUNOLOGY, 1994, 152 (02): : 405 - 412
  • [3] Identification of a CD4 variant in Microminipigs not detectable with available anti-CD4 monoclonal antibodies
    Matsubara, Tatsuya
    Nishii, Naohito
    Takashima, Satoshi
    Takasu, Masaki
    Imaeda, Noriaki
    Aiki-Oshimo, Kayo
    Yamazoe, Kazuaki
    Kametani, Yoshie
    Ando, Asako
    Kitagawa, Hitoshi
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2015, 168 (3-4) : 176 - 183
  • [4] ANTI-CD4 PREFERENTIALLY ELIMINATES NAIVE CD4 CELLS AND SPARES PREACTIVATED CD4 CELLS
    FIELD, EH
    CHACE, JH
    COWDERY, JS
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S47 - S47
  • [5] Modulation of the CD4 molecule is a major event in the induction of transplantation tolerance with anti-CD4 monoclonal antibodies
    Saitovitch, D
    Bushell, A
    Morris, PJ
    Wood, KJ
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 1159 - 1159
  • [6] THERAPEUTIC APPLICATIONS OF ANTI-CD4 ANTIBODIES
    OLIVE, D
    MAWAS, C
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1993, 10 (01): : 29 - 63
  • [7] IMMUNOINTERVENTION IN PSORIASIS WITH ANTI-CD4 ANTIBODIES
    THIVOLET, J
    NICOLAS, JF
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1994, 33 (05) : 327 - 332
  • [8] ANTI-CD4 AUTOANTIBODIES AND SCREENING FOR ANTIIDIOTYPIC ANTIBODIES TO ANTI-CD4 MONOCLONAL-ANTIBODIES IN HIV-SEROPOSITIVE PEOPLE
    WILKS, D
    WALKER, LC
    HABESHAW, JA
    YOULE, M
    GAZZARD, B
    DALGLEISH, AG
    AIDS, 1990, 4 (02) : 113 - 118
  • [9] CD4+ T cell apoptosis induced by anti-CD4 antibodies
    Zhihong Z.
    Yue Z.
    Huifen Z.
    Jing Y.
    Guanxin S.
    Current Medical Science, 2000, 20 (2) : 100 - 102
  • [10] CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized™ monoclonal anti-CD4 treatment of active rheumatoid arthritis
    Mason, U
    Aldrich, J
    Breedveld, F
    Davis, CB
    Elliott, M
    Jackson, M
    Jorgensen, C
    Keystone, E
    Levy, R
    Tesser, J
    Totoritis, M
    Truneh, A
    Weisman, M
    Wiesenhutter, C
    Yocum, D
    Zhu, J
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (02) : 220 - 229